<?xml version="1.0" encoding="UTF-8"?>
<p id="p0150">Many of the proposed systemic therapies such as chloroquine, zinc and ACE inhibitors have all been used topically in the eye (
 <xref rid="tbl2" ref-type="table">Table 2</xref>). Chloroquine as 0.03% chloroquine phosphate eye drops have apparently been efficacious in the management of dry eye syndrome in humans [
 <xref rid="bib75" ref-type="bibr">75</xref>,
 <xref rid="bib76" ref-type="bibr">76</xref>]. Significant side effects were not reported, however there is a report of chloroquine keratopathy in workers chronically exposed to chloroquine dust [
 <xref rid="bib103" ref-type="bibr">103</xref>]. Chronic usage is unlikely in the setting here proposed.
</p>
